Clinical Trials Browser

Phase 2 × Locally Advanced Non-small Cell Lung Cancer × Clear all

NCT05481775 2022-11-21

Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Phase 2 Withdrawn

Locally Advanced Non-small Cell Lung Cancer

NCT03371550 2017-12-13

TAXCIS

Phase 2 Completed

Locally Advanced Non-small Cell Lung Cancer